ArticleActa pharmacologica Sinica2019

SHR-A1403, a novel c-Met antibody-drug conjugate, exerts encouraging anti-tumor activity in c-Met-overexpressing models.

Chang-Yong Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.